Publicaciones recientes

Lista de publicaciones más recientes lideradas por la Unidad de Memoria del Hospital de Sant Pau:

  1. Biomarkers in neurological disorders: a fast-growing market. Lleó, A Brain Commun 2021
    PMID:33977270

  2. AMYQ: An index to standardize quantitative amyloid load across PET tracers. Pegueroles, J, Montal, V, Bejanin, A et al. Alzheimers Dement 2021
    PMID:33797846

  3. Diagnostic Utility of Measuring Cerebral Atrophy in the Behavioral Variant of Frontotemporal Dementia and Association With Clinical Deterioration. Illán-Gala, I, Falgàs, N, Friedberg, A et al. JAMA Netw Open 2021
    PMID:33704477

  4. Sex differences in the behavioral variant of frontotemporal dementia: A new window to executive and behavioral reserve. Illán-Gala, I, Casaletto, KB, Borrego-Écija, S et al. Alzheimers Dement 2021
    PMID:33590953

  5. Plasma Tau and Neurofilament Light in Frontotemporal Lobar Degeneration and Alzheimer Disease. Illán-Gala, I, Lleo, A, Karydas, A et al. Neurology 2021
    PMID:33199433

  6. Biphasic cortical macro- and microstructural changes in autosomal dominant Alzheimer's disease. Montal, V, Vilaplana, E, Pegueroles, J et al. Alzheimers Dement 2021
    PMID:33196147

  7. Heterozygous APOE Christchurch in familial Alzheimer's disease without mutations in other Mendelian genes. Hernandez, I, Gelpi, E, Molina-Porcel, L et al. Neuropathol Appl Neurobiol 2021
    PMID:33095930

  8. Genetic-environmental factors finally assessed together in Parkinson's disease. Clarimón, J J Neurol Neurosurg Psychiatry 2020
    PMID:32934106

  9. Cortical microstructure in the amyotrophic lateral sclerosis-frontotemporal dementia continuum. Illán-Gala, I, Montal, V, Pegueroles, J et al. Neurology 2020
    PMID:32913016

  10. Cerebrospinal fluid profile of NPTX2 supports role of Alzheimer's disease-related inhibitory circuit dysfunction in adults with Down syndrome. Belbin, O, Xiao, MF, Xu, D et al. Mol Neurodegener 2020
    PMID:32807227

  11. Motor cortex transcriptome reveals microglial key events in amyotrophic lateral sclerosis. Dols-Icardo, O, Montal, V, Sirisi, S et al. Neurol Neuroimmunol Neuroinflamm 2020
    PMID:32669313

  12. Diagnosis of prodromal and Alzheimer's disease dementia in adults with Down syndrome using neuropsychological tests. Benejam, B, Videla, L, Vilaplana, E et al. Alzheimers Dement (Amst) 2020
    PMID:32613076

  13. Clinical and biomarker changes of Alzheimer's disease in adults with Down syndrome: a cross-sectional study. Fortea, J, Vilaplana, E, Carmona-Iragui, M et al. Lancet 2020
    PMID:32593336

  14. Differential levels of Neurofilament Light protein in cerebrospinal fluid in patients with a wide range of neurodegenerative disorders. Delaby, C, Alcolea, D, Carmona-Iragui, M et al. Sci Rep 2020
    PMID:32514050

  15. Assessing circular RNAs in Alzheimer's disease and frontotemporal lobar degeneration. Cervera-Carles, L, Dols-Icardo, O, Molina-Porcel, L et al. Neurobiol Aging 2020
    PMID:32335360

  16. Atrophy of Basal Forebrain Initiates with Tau Pathology in Individuals at Risk for Alzheimer's Disease. Cantero, JL, Atienza, M, Lage, C et al. Cereb Cortex 2020
    PMID:31799623

  17. APP-derived peptides reflect neurodegeneration in frontotemporal dementia. Illán-Gala, I, Pegueroles, J, Montal, V et al. Ann Clin Transl Neurol 2019
    PMID:31789459

  18. The Sant Pau Initiative on Neurodegeneration (SPIN) cohort: A data set for biomarker discovery and validation in neurodegenerative disorders. Alcolea, D, Clarimón, J, Carmona-Iragui, M et al. Alzheimers Dement (N Y) 2019
    PMID:31650016

  19. Agreement of amyloid PET and CSF biomarkers for Alzheimer's disease on Lumipulse. Alcolea, D, Pegueroles, J, Muñoz, L et al. Ann Clin Transl Neurol 2019
    PMID:31464088

  20. Down syndrome, Alzheimer disease, and cerebral amyloid angiopathy: The complex triangle of brain amyloidosis. Carmona-Iragui, M, Videla, L, Lleó, A et al. Dev Neurobiol 2019
    PMID:31278851

  21. Different pattern of CSF glial markers between dementia with Lewy bodies and Alzheimer's disease. Morenas-Rodríguez, E, Alcolea, D, Suárez-Calvet, M et al. Sci Rep 2019
    PMID:31127154

  22. Nanoscale structure of amyloid-β plaques in Alzheimer's disease. Querol-Vilaseca, M, Colom-Cadena, M, Pegueroles, J et al. Sci Rep 2019
    PMID:30914681

  23. Cortical microstructure in the behavioural variant of frontotemporal dementia: looking beyond atrophy. Illán-Gala, I, Montal, V, Borrego-Écija, S et al. Brain 2019
    PMID:30906945

  24. Changes in Synaptic Proteins Precede Neurodegeneration Markers in Preclinical Alzheimer's Disease Cerebrospinal Fluid. Lleó, A, Núñez-Llaves, R, Alcolea, D et al. Mol Cell Proteomics 2019
    PMID:33431128

  25. Changes in Synaptic Proteins Precede Neurodegeneration Markers in Preclinical Alzheimer's Disease Cerebrospinal Fluid. Lleó, A, Núñez-Llaves, R, Alcolea, D et al. Mol Cell Proteomics 2019
    PMID:30606734

  26. Impact of CSF storage volume on the analysis of Alzheimer's disease biomarkers on an automated platform. Delaby, C, Muñoz, L, Torres, S et al. Clin Chim Acta 2019
    PMID:30579960

  27. Obesity and Alzheimer's disease, does the obesity paradox really exist? A magnetic resonance imaging study. Pegueroles, J, Jiménez, A, Vilaplana, E et al. Oncotarget 2018
    PMID:30410669

  28. Prevalence of Sleep Disorders in Adults With Down Syndrome: A Comparative Study of Self-Reported, Actigraphic, and Polysomnographic Findings. Giménez, S, Videla, L, Romero, S et al. J Clin Sleep Med 2018
    PMID:30353801

  29. Elevated YKL-40 and low sAPPβ:YKL-40 ratio in antemortem cerebrospinal fluid of patients with pathologically confirmed FTLD. Alcolea, D, Irwin, DJ, Illán-Gala, I et al. J Neurol Neurosurg Psychiatry 2019
    PMID:30297518

Search PubMed